National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

PI3K inhibitor BEZ235
An orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. PI3K inhibitor BEZ235 specifically inhibits PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway, which may trigger the translocation of cytosolic Bax to the mitochondrial outer membrane, increasing mitochondrial membrane permeability; apoptotic cell death may ensue. Bax is a member of the proapoptotic Bcl2 family of proteins. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:BEZ235



Previous:Photochlor, Photofrin, phytochemical, PI-88, PI3K delta inhibitor CAL-101
Next:PI3K inhibitor BGT226, PI3K inhibitor GSK1059615, PI3K inhibitor PX-866, PI3K/mTOR dual kinase inhibitor XL765, pibenzimol

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov